MAPK3 and neoplasm: BRAFVal600 phosphorylates and activates Mitogen-activated protein kinase kinase 1 (MEK1) and MEK2, which in turn phosphorylate and activate ERK1/2, stimulating the MAPK pathway and ultimately promoting tumor growth.